Edwards Lifesciences (EW) return on equity (ROE)

Return on equity · fiscal 2025
10.4%

Edwards Lifesciences (EW) earned a return on equity of 10.4% in fiscal 2025 (the year ended December 31, 2025). That is 31.4 percentage points lower than the 41.8% of fiscal 2024. Figures as of 17 Nov 2026, 17:27 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Return on equity, fiscal 2025
10.4%
Change on fiscal 2024
−31.4 pts
Highest on record
41.8%fiscal 2024
Lowest on record
10.4%fiscal 2025
Fiscal years on record
82008–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Figures, not advice.

Edwards Lifesciences return on equity (ROE), in more detail

Across the 8 fiscal years on record (2008–2025), the highest was 41.8% in fiscal 2024 and the lowest 10.4% in fiscal 2025. The fiscal 2025 figure is no higher than in any of the 7 earlier fiscal years on record, whose median is 21.1%.

History · 8 fiscal years

Return on equity by fiscal year

Edwards Lifesciences return on equity (ROE), year by year

Edwards Lifesciences (EW) return on equity (ROE) by fiscal year
Fiscal yearReturn on equityChangeYear ended
202510.4% 31.4 pts down
202441.8% 20.7 pts up
202321.1% 5.1 pts down
202226.2% 0.5 pts up
202125.8%—
201016.7% 3.1 pts down
200919.8% 5.1 pts up
200814.7%—

Change is on the fiscal year before, in percentage points; a dash means that year is not on record. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Return on equity is net income divided by shareholders' equity at the fiscal year-end; it is left blank when equity is negative.

How to read it

It is the profit earned on the owners' capital — above about 15% is strong, though heavy debt or large buybacks can inflate it.

Return on equity at health care companies of similar size

Return on equity of Edwards Lifesciences and comparable companies
CompanyReturn on equityFiscal year
Boston Scientific BSX12.0%2025
Cardinal Health CAH34.1%2021
argenx ARGX17.6%2025
Edwards Lifesciences EW10.4%2025
Becton, Dickinson BDX6.6%2025
IDEXX Laboratories IDXX66.0%2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on EW

Edwards Lifesciences, figure by figure

Edwards Lifesciences (EW) overview: price, valuation and scorecardAll health care companies by market value

Edwards Lifesciences return on equity (ROE): questions and answers

What is Edwards Lifesciences's return on equity?

Edwards Lifesciences (EW) earned a return on equity of 10.4% in fiscal 2025 (the year ended December 31, 2025). That is 31.4 percentage points lower than the 41.8% of fiscal 2024.

Is Edwards Lifesciences's return on equity high or low compared with its own history?

The fiscal 2025 figure is no higher than in any of the 7 earlier fiscal years on record, whose median is 21.1%.

What are the highest and lowest return on equity figures on record for Edwards Lifesciences?

Across the 8 fiscal years on record (2008–2025), the highest was 41.8% in fiscal 2024 and the lowest 10.4% in fiscal 2025.

How is Edwards Lifesciences's return on equity calculated?

Return on equity is net income divided by shareholders' equity at the fiscal year-end; it is left blank when equity is negative.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Edwards Lifesciences (EW) return on equity (ROE)”, data as of 17 November 2026. https://funkfolio.com/stock/EW/roe

Underlying data: the company's filings with the SEC and Yahoo Finance.